IDEAS home Printed from https://ideas.repec.org/h/spr/advbcp/978-94-6463-098-5_28.html

The Strategy Research of Pharmaceutical Enterprises-Taking Pfizer as an Example

In: Proceedings of the 2022 4th International Conference on Economic Management and Cultural Industry (ICEMCI 2022)

Author

Listed:
  • Siyuan Yang

    (University of Manchester, Alliance Manchester Business School)

Abstract

The entire pharmaceutical industry has experienced high-speed growth in the past 30 years using different strategies. This paper will evaluate different kinds of strategies run by pharmaceutical enterprises, taking Pfizer as an example, and see how effective they are. The issues and obstacles of the strategies will also be addressed. In this paper, we can see that Pfizer keeps benefitting from its strategies such as blockbuster drugs, M&As and restruction of employees in the last two decades, which helps it lead the pharmaceutical industry. In the future, Pfizer will continue researching blockbuster drugs and conducting M&As supported by the considerable Covid-19 vaccine income to remain the seat in the industry.

Suggested Citation

  • Siyuan Yang, 2023. "The Strategy Research of Pharmaceutical Enterprises-Taking Pfizer as an Example," Advances in Economics, Business and Management Research, in: Hrushikesh Mallick & Gaikar Vilas B. & Ong Tze San (ed.), Proceedings of the 2022 4th International Conference on Economic Management and Cultural Industry (ICEMCI 2022), pages 228-235, Springer.
    • Handle: RePEc:spr:advbcp:978-94-6463-098-5_28
    DOI: 10.2991/978-94-6463-098-5_28
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:advbcp:978-94-6463-098-5_28. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.